The "magic of the profit-making effect" is frequently appearing! NVIDIA's latest investment blueprint has been released, and these 13 companies are expected to take off.

Apart from NVIDIA itself, the key tracks and companies it invests in and pays attention to are also frequently favored by the U.S. stock market. The market believes that NVIDIA's investments often represent the development direction of the Industry, reflect the key areas of AI technology applications, and hint at potential technological breakthroughs.

Futu NewsJan 7 19:07

Recursion Pharmaceuticals Announces 2 Key Investigational Oncology Drugs Advancing To Clinical Trials, Targeting High Unmet Needs In Hematologic Malignancies, Small-Cell Lung Cancer, & More

BenzingaJan 7 22:16

Express News | Recursion Pharmaceuticals Inc - First Patient to Be Dosed in Phase 1 Excelerize Trial in Q1 2025

BreakingsJan 7 22:15

Express News | Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

BreakingsJan 7 22:15

BofA Securities Maintains Recursion Pharmaceuticals(RXRX.US) With Hold Rating, Cuts Target Price to $10

Futu NewsJan 7 21:35 · Ratings

Express News | Recursion Pharmaceuticals Inc : BofA Global Research Cuts Price Objective to $10 From $12

BreakingsJan 7 21:31